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Superficial thrombophlebitis is a common inflammatory-thrombotic disorder in which a thrombus develops in a vein located near the surface of the skin (Markovic et al., 1997)
Most superficial veins that develop thrombosis also have phlebitis, in contrast to deep venous thrombosis (DVT), a sometimes asymptomatic condition in which phlebitis may be absent
Although superficial thrombophlebitis usually occurs in the lower extremities (saphenous vein of the leg), it also has been described in the penis and the breast (Mondor disease) (Nazir and Khan.2010)
It can also develop anywhere that medical interventions occur, as in the arm or neck (external jugular vein) when intravenous (IV) catheters are used. Thrombosis of superficial veins has long been regarded as a benign disorder and a selflimiting, however, it can be complicated by deep vein thrombosis (DVT) and even pulmonary embolism (PE).
65.6% of patients who presented with great saphenous vein thrombosis were found to have associated DVT (Ascher et al., 2003) .
Pathophysiology
Vascular endothelial injury as triggering agent result in thrombus formation. This injury initiates an inflammatory response that results in immediate platelet adhesion at the injury site. Further platelet aggregation is mediated by thromboxane A2 (TxA2) and by thrombin.
Fig(1)coagulation cascade
Platelet aggregation due to TxA2 is inhibited irreversibly by aspirin and reversibly by other nonsteroidal anti-inflammatory drugs (NSAIDs); thrombin-mediated platelet aggregation, on the other hand, is not affected by NSAIDs, including aspirin. Patient characteristics and predisposing factors for thrombophlebitis nearly mirror those for DVT; thrombophlebitis is a risk factor for the development of DVT, and vice versa.
Contributing Risk factors include,
Lower extremity superficial phlebitis is associated with conditions that increase the risk of thrombosis, including abnormalities of coagulation or fibrinolysis, endothelial dysfunction, infection, venous stasis, intravenous therapy and intravenous drug abuse which are components of virchows triad (Fernandez et al., 2012) Duplex ultrasound identifies the presence, location and extent of venous thrombosis, also may identify the pathology that may be a source of the patient's complaints.
Fig(3) fig(4) Thrombus extending in the proliferating vein.
Ultrasound is indicated if superficial phlebitis involves or extends into the proximal onethird of the medial thigh otherwise clinical diagnosis will be enough (Fernandez et al., 2010) . Current treatment options are aimed at resolving symptoms, preventing recurrence and preventing extension to the deep venous system, for potentiality of thromboembolism.
Treatment with compression stockings should be offered to patients with lower extremity superficial phlebitis, if not contraindicated (e.g., peripheral artery disease).
Gradient compression stockings are adjunctive therapy that is both benign and effective. They provide a gradient of compression that is highest at the toes (at least 30-40 mm Hg) and gradually decreases to the level of the thigh. Which reduces capacitive venous volume by approximately 70% and increases the measured velocity of blood flow in the deep veins by a factor of 5 or more.
Gradient compression hose also have been shown to increase local and regional intrinsic fibrinolytic activity. Patients may find them helpful for reducing swelling and pain once the acute inflammation subsides.
Non-steroidal anti-inflammatory drugs (NSAID) are effective in relieving the pain associated with venous inflammation and were found in a randomized trial to significantly decrease extension and/or the recurrence of superficial vein thrombosis. In a small, randomized trial of 60 patients with great saphenous vein thrombosis, Lozano et al compared treatment using LMWH with surgical saphenous ligation, Patients in the LMWH group experienced no episodes of DVT or PE but had a 10% incidence of recurrent superficial venous thrombosis.
Among the patients treated surgically, two pulmonary emboli (6.7%) were found, and one episode of recurrent superficial venous thrombosis (3.3%) occurred Complications recorded include superficial vein thrombosis extension to the deep vein system and/or recurrence of SVT.
Supportive thrombophlebitis is suspected when erythema extends significantly beyond the margin of the vein and is associated with significant fever. If suspected, antibiotic treatment, surgical drainage and potentially vein excision are indicated (Davidovic et al., 1990) Venous thromboembolism can occur with superficial vein thrombosis. Estimates of the percentage of patients with SVT who also have DVT vary between 6% and 53%, and symptomatic pulmonary embolism has been reported in 0% to 10% of patients with SVT. (Decousus et al., 2010) 
